Skip to main content
. 2022 Jul 26;43(45):4722–4735. doi: 10.1093/eurheartj/ehac363

Figure 2.

Figure 2

Cardiac systemic light-chain amyloid progression on serial cardiovascular magnetic resonance scans at baseline (top row) and after treatment with chemotherapy at 6 months (second row). Increase in native T1, late gadolinium enhancement, and extracellular volume within the myocardium are demonstrated after not achieving good response to chemotherapy at 6 months.